These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 17097963

  • 1. Posttransplant lymphoproliferative disease: a series of 23 cases.
    Martín-Gómez MA, Peña M, Cabello M, Burgos D, Gutierrez C, Sola E, Acedo C, Bailén A, Gonzalez-Molina M.
    Transplant Proc; 2006 Oct; 38(8):2448-50. PubMed ID: 17097963
    [Abstract] [Full Text] [Related]

  • 2. Posttransplant lymphoproliferative disorders in transplant recipients.
    Timurağaoğlu A, Uğur-Bilgin A, Colak D, Tuncer M, Gölbaşi I, Hazar V, Kiliçarsłan B, Undar L, Demirbaş A.
    Transplant Proc; 2006 Mar; 38(2):641-5. PubMed ID: 16549195
    [Abstract] [Full Text] [Related]

  • 3. Epstein-Barr virus seronegativity is a risk factor for late-onset posttransplant lymphoroliferative disorder in adult renal allograft recipients.
    Shahinian VB, Muirhead N, Jevnikar AM, Leckie SH, Khakhar AK, Luke PP, Rizkalla KS, Hollomby DJ, House AA.
    Transplantation; 2003 Mar 27; 75(6):851-6. PubMed ID: 12660514
    [Abstract] [Full Text] [Related]

  • 4. Long-term follow-up of kidney transplant patients with posttransplant lymphoproliferative disorder: duration of posttransplant lymphoproliferative disorder-induced operational graft tolerance, interleukin-18 course, and results of retransplantation.
    Birkeland SA, Hamilton-Dutoit S, Bendtzen K.
    Transplantation; 2003 Jul 15; 76(1):153-8. PubMed ID: 12865802
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.
    Oertel S, Trappe RU, Zeidler K, Babel N, Reinke P, Hummel M, Jonas S, Papp-Vary M, Subklewe M, Dörken B, Riess H, Gärtner B.
    Ann Hematol; 2006 Jul 15; 85(7):478-84. PubMed ID: 16586109
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Analysis of risk factors for the development of posttransplant lymphoprolipherative disorder among 119 children who received primary intestinal transplants at a single center.
    Quintini C, Kato T, Gaynor JJ, Ueno T, Selvaggi G, Gordon P, McLaughlin G, Tompson J, Ruiz P, Tzakis A.
    Transplant Proc; 2006 Jul 15; 38(6):1755-8. PubMed ID: 16908272
    [Abstract] [Full Text] [Related]

  • 11. The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation.
    Sundin M, Le Blanc K, Ringdén O, Barkholt L, Omazic B, Lergin C, Levitsky V, Remberger M.
    Haematologica; 2006 Aug 15; 91(8):1059-67. PubMed ID: 16885046
    [Abstract] [Full Text] [Related]

  • 12. Posttransplantation lymphoproliferative disorders in renal transplant recipients: report of over 20 years of experience.
    Saadat A, Einollahi B, Ahmadzad-Asl MA, Moradi M, Nafar M, Pourfarziani V, Firoozan A, Porrezagholi F, Davoudi F.
    Transplant Proc; 2007 May 15; 39(4):1071-3. PubMed ID: 17524894
    [Abstract] [Full Text] [Related]

  • 13. Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se?
    Birkeland SA, Hamilton-Dutoit S.
    Transplantation; 2003 Sep 27; 76(6):984-8. PubMed ID: 14508366
    [Abstract] [Full Text] [Related]

  • 14. Early posttransplant lymphoproliferative disease in pediatric liver transplant recipients.
    Roque J, Rios G, Humeres R, Volpi C, Herrera JM, Schultz M, Rios H, Rius M, Salgado C, Hepp J.
    Transplant Proc; 2006 Apr 27; 38(3):930-1. PubMed ID: 16647513
    [Abstract] [Full Text] [Related]

  • 15. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
    Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Yegitbasi M, Reinke P, Kebelmann-Betzig C, Hauptmann K, Gross-Wieltsch U, Hetzer R, Berger F.
    Pediatr Transplant; 2009 Feb 27; 13(1):54-62. PubMed ID: 18518912
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies.
    Boratyńska M, Watorek E, Smolska D, Patrzałek D, Klinger M.
    Transplant Proc; 2007 Nov 27; 39(9):2736-9. PubMed ID: 18021973
    [Abstract] [Full Text] [Related]

  • 19. Post-transplant lymphoproliferative disorder following pediatric heart transplantation.
    Mendoza F, Kunitake H, Laks H, Odim J.
    Pediatr Transplant; 2006 Feb 27; 10(1):60-6. PubMed ID: 16499589
    [Abstract] [Full Text] [Related]

  • 20. Post-transplant lymphoproliferative disorder following renal transplantation: a single-center experience over 40 years.
    Abe T, Ichimaru N, Kokado Y, Maeda T, Kakuta Y, Okumi M, Imamura R, Nonomura N, Isaka Y, Takahara S, Okuyama A.
    Int J Urol; 2010 Jan 27; 17(1):48-54. PubMed ID: 20002504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.